June 26 (Reuters) - Cleo Diagnostics Ltd (COV) :
- COMMENCES U.S. REGULATORY PROCESS WITH FDA
- COMPLETED AN INITIAL PRE-SUBMISSION MEETING WITH FDA
- OUTLINED ITS SUBMISSION FRAMEWORK AND CLINICAL PLAN FOR ITS OVARIAN CANCER DETECTION BLOOD TEST WITH FDA
(([email protected];))
News: COV Cleo Diagnostics Commences U.S. Regulatory Process With FDA
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
-0.005(1.32%) |
Mkt cap ! $30.6M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.5¢ | 37.5¢ | $33.42K | 87.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11247 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 17188 | 2 |
View Market Depth
| Last trade - 10.16am 07/08/2025 (20 minute delay) ? |
| COV (ASX) Chart |